litlas
Log inCreate account

Ayalew Tefferi

Active 1989–2025

455
Papers
84,209
Citations
154
h-index
439
i10-index

Citations

Citations per year for Ayalew Tefferi1975: 1 citations1979: 4 citations1980: 2 citations1982: 7 citations1983: 3 citations1984: 1 citations1986: 4 citations1988: 2 citations1989: 4 citations1990: 4 citations1991: 9 citations1992: 10 citations1993: 9 citations1994: 10 citations1995: 9 citations1996: 21 citations1997: 15 citations1998: 17 citations1999: 22 citations2000: 43 citations2001: 75 citations2002: 81 citations2003: 181 citations2004: 241 citations2005: 334 citations2006: 408 citations2007: 503 citations2008: 520 citations2009: 580 citations2010: 598 citations2011: 645 citations2012: 750 citations2013: 833 citations2014: 717 citations2015: 768 citations2016: 660 citations2017: 500 citations2018: 531 citations2019: 1,571 citations2020: 2,082 citations2021: 1,767 citations2022: 1,571 citations2023: 1,211 citations2024: 2,193 citations2025: 848 citations2026: 7 citations1976–1978: no citations, so these years are not shown1981: no citations, so this year is not shown1985: no citations, so this year is not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,235 citing papers, 29.8% of this breakdownItaly: 1,163 citing papers, 8.2% of this breakdownGermany: 1,056 citing papers, 7.4% of this breakdownUnited Kingdom: 925 citing papers, 6.5% of this breakdownFrance: 881 citing papers, 6.2% of this breakdownChina: 636 citing papers, 4.5% of this breakdownSpain: 514 citing papers, 3.6% of this breakdownCanada: 406 citing papers, 2.9% of this breakdownNetherlands: 331 citing papers, 2.3% of this breakdownSwitzerland: 330 citing papers, 2.3% of this breakdownAustria: 319 citing papers, 2.2% of this breakdownJapan: 313 citing papers, 2.2% of this breakdown
0%29.8%Other 21.9%

Institutions

Fields

  • Medicine78.9%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Immunology and Microbiology6.1%
  • Computer Science0.6%
  • Chemistry0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other1.1%

Topics

  • Myeloproliferative Neoplasms: Diagnosis and Treatment12.3%
  • Acute Myeloid Leukemia Research12%
  • Chronic Myeloid Leukemia Treatments5.3%
  • Eosinophilic Disorders and Syndromes4.9%
  • Kruppel-like factors research3.3%
  • Chronic Lymphocytic Leukemia Research2%
  • Other60.2%

Coauthors

All papers

Open in search
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Authors: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 cited by 2,693

  2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

    Authors: James W. Vardiman, Jüergen Thiele, Daniel A. Arber, Richard D. Brunning, Michael J. Borowitz, Anna Porwit, Nancy L. Harris, Michelle M. Le Beau, Eva Hellström‐Lindberg, Ayalew Tefferi, Clara D. Bloomfield - Blood 2009 cited by 4,416

  3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    Authors: Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Włodarska, Jennifer Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D. D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland - Cancer Cell 2005 cited by 2,991

  4. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    Authors: Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna Brown, Catherine Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia‐Manero, Torsten Haferlach, Eva Hellström‐Lindberg, Annette S. Kim, Jeffery M. Klco, Rami S. Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 cited by 208

  5. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    Authors: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli, Maura Nicolosi, Annalisa Pacilli, Animesh Pardanani, Elisa Rumi, Vittorio Rosti, Curtis A. Hanson, Francesco Mannelli, Rhett P. Ketterling, Naseema Gangat, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi, Ayalew Tefferi - Journal of Clinical Oncology 2017 cited by 532

  6. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

    Authors: Animesh Pardanani, Claire Harrison, Jörge E. Cortes, Francisco Cervantes, Ruben A. Mesa, Donald Milligan, Tamás Masszi, Elena Mishchenko, Éric Jourdan, Alessandro M. Vannucchi, Mark W. Drummond, Mindaugas Jurgutis, Kazimierz Kuliczkowski, Emanuil Gheorghita, Francesco Passamonti, Frank Neumann, Abhay Patki, Guozhi Gao, Ayalew Tefferi - JAMA Oncology 2015 cited by 472

  7. Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management

    Authors: Ayalew Tefferi - American Journal of Hematology 2023 cited by 271

  8. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Authors: Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino, Marianna Caramella, Margherita Maffioli, Cristiana Pascutto, Mario Lazzarino, Mario Cazzola, Ayalew Tefferi - Blood 2009 cited by 968

  9. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

    Authors: Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M. Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi - Blood Cancer Journal 2018 cited by 640

  10. DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Authors: Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Geeta George, Kebede H. Begna, Susan M. Schwager, Daniel Van Dyke, Curtis A. Hanson, Wenting Wu, Animesh Pardanani, Francisco Cervantes, Francesco Passamonti, Ayalew Tefferi - Journal of Clinical Oncology 2010 cited by 1,032

  11. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

    Authors: Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy M. Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi - Blood 2014 cited by 727

  12. Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

    Authors: Ayalew Tefferi, Rakhee Vaidya, Domenica Caramazza, Christy M. Finke, Terra L. Lasho, Animesh Pardanani - Journal of Clinical Oncology 2011 cited by 586

  13. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    Authors: Tiziano Barbui, Ayalew Tefferi, Alessandro M. Vannucchi, Francesco Passamonti, Richard T. Silver, Ronald Hoffman, Srđan Verstovšek, Ruben A. Mesa, Jean‐Jacques Kiladjian, Rȕdiger Hehlmann, Andreas Reiter, Francisco Cervantes, Claire Harrison, Mary Frances Mc Mullin, Hans Carl Hasselbalch, Steffen Koschmieder, Monia Marchetti, Andrea Bacigalupo, Guido Finazzi, Nicolaus Kröger, Martin Grießhammer, Gunnar Birgegård, Giovanni Barosi - Leukemia 2018 cited by 552

  14. MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    Authors: Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Naseema Gangat, Rhett P. Ketterling, Animesh Pardanani, Alessandro M. Vannucchi - Journal of Clinical Oncology 2018 cited by 383

  15. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

    Authors: Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean‐Loup Demory, Giovanni Barosi, Elisa Rumi, Ayalew Tefferi - Blood 2008 cited by 1,237

  16. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Authors: Ayalew Tefferi, Francisco Cervantes, Ruben A. Mesa, Francesco Passamonti, Srđan Verstovšek, Alessandro M. Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison, Ronald Hoffman, Heinz Gisslinger, Nicolaus Kröger, Jüergen Thiele, Tiziano Barbui, Giovanni Barosi - Blood 2013 cited by 379

  17. Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

    Authors: Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla McKerrow Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek A. Mangaonkar, Antoine N. Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi - American Journal of Hematology 2023 cited by 75

  18. Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management

    Authors: Ayalew Tefferi, Tiziano Barbui - American Journal of Hematology 2023 cited by 187

  19. Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management

    Authors: Ayalew Tefferi - American Journal of Hematology 2020 cited by 303

  20. Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

    Authors: Tiziano Barbui, Guido Finazzi, Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Valerio De Stefano, Silvia Betti, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi - Blood 2012 cited by 589

  21. Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

    Authors: Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Giacomo Coltro, Christy M. Finke, Giuseppe Gaetano Loscocco, Benedetta Sordi, Natasha Szuber, Giada Rotunno, Annalisa Pacilli, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi - British Journal of Haematology 2020 cited by 221

  22. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group

    Authors: Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, Markus Ditschkowski, Nico Gagelmann, Martin Grießhammer, Vikas Gupta, Nada Hamad, Claire Harrison, Juan Carlos Hernández‐Boluda, Steffen Koschmieder, Tania Jain, John Mascarenhas, Ruben A. Mesa, Uday Popat, Francesco Passamonti, Nicola Polverelli, Alessandro Rambaldi, Marie Robin, Rachel B. Salit, Thomas Schroeder, Bart L. Scott, Roni Tamari, Ayalew Tefferi, Alessandro M. Vannucchi, Donal P. McLornan, Giovanni Barosi - The Lancet Haematology 2023 cited by 96

  23. Mutations and prognosis in primary myelofibrosis

    Authors: A. M. Vannucchi, T L Lasho, Paola Guglielmelli, Flavia Biamonte, Animesh Pardanani, Arturo Pereira, Christy M. Finke, J Score, Naseema Gangat, C Mannarelli, Rhett P. Ketterling, Giada Rotunno, R A Knudson, M C Susini, Rebecca R. Laborde, Ambra Spolverini, Alessandro Pancrazzi, Lisa Pieri, Rossella Manfredini, Enrico Tagliafico, Roberta Zini, Amy V. Jones, Katerina Zoi, Andreas Reiter, Andrew Duncombe, Daniela Pietra, Elisa Rumi, Francisco Cervantes, Giovanni Barosi, Mario Cazzola, Nicholas C.P. Cross, Ayalew Tefferi - Leukemia 2013 cited by 746

  24. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Authors: Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean‐Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández‐Maraver, Heike L. Pahl, Martin Grießhammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Françoise Boyer, Gabriel Étienne, Jean‐Christophe Ianotto, Dana Ranta, Lydia Roy, Jean‐Yves Cahn, Claire Harrison, Deepti Radia, Pablo Muxí, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Björn Andréasson, Maria L Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegård, Ayalew Tefferi, Ruben A. Mesa - Journal of Clinical Oncology 2012 cited by 458